1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

mylan

  1. StepAK2018
  2. StepAK2018
  3. anonymous
  4. anonymous
  5. RobertPhillips900
  6. anonymous
  7. anonymous
  8. anonymous
  9. anonymous
  10. anonymous
  11. anonymous
  12. anonymous
  13. allergiessuck
  14. anonymous